STAR-AD: Testing stepwise treatment for teen depression
Part of Mental health clinical trials.
This trial tests a step-by-step approach to treating moderate-to-severe depression in teens. It may help find a treatment path that improves mood while keeping care safe, including for some teens who have suicidal thoughts but do not need inpatient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 13 and 18 years old
- You have a diagnosis of major depression (depression) without psychosis, confirmed by a structured interview
- Your depression symptom score is high enough (CDRS-R score 40 or higher)
- You can do study tasks (including having enough ability to hear/see and understand instructions)
- You and at least one parent/guardian can sign consent in writing
- If you are having suicidal thoughts, your care team must think outpatient treatment is safe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether stopping treatment early affects depression outcomes in teens and young adults. It is mainly for people recently diagnosed with depression who need treatment but can participate in psychological therapy.
This study looks at how a therapy approach called behavioral activation may affect depression in teens. It also uses brief daily check-ins on a phone to understand what changes during treatment.
This study tests whether switching to a different antidepressant or adding a second medication works better for teens (12-17) whose depression hasn't improved with a first SSRI. It compares two common strategies to find the best next step.
This trial tests if a gentle electrical brain stimulation called tACS can help teens with depression who are already on stable medication. The treatment is added to their usual medication to see if it improves mood.
This study tests whether a structured, coordinated care pathway helps teens (and their caregivers) manage depression better than usual care. It aims to see if targeted treatment and follow-up improve depression symptoms over time.
This trial studies how fluoxetine or escitalopram (anti-depression medicines) may affect brain systems involved in feeling threatened and staying anxious when you have depression. It also uses brain scanning and blood tests to measure these changes.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.